Literature DB >> 20844068

Random serial sampling to evaluate efficacy of iron fortification: a randomized controlled trial of margarine fortification with ferric pyrophosphate or sodium iron edetate.

Maria Andersson1, Winfried Theis, Michael B Zimmermann, Jasmin Tajeri Foman, Martin Jäkel, Guus S M J E Duchateau, Leon G J Frenken, Richard F Hurrell.   

Abstract

BACKGROUND: Random serial sampling is widely used in population pharmacokinetic studies and may have advantages compared with conventional fixed time-point evaluation of iron fortification.
OBJECTIVE: Our objective was to validate random serial sampling to judge the efficacy of iron fortification of a low-fat margarine.
DESIGN: We conducted a 32-wk placebo-controlled, double-blind, iron-intervention trial in 18-40-y-old Swiss women (n = 142) with serum ferritin (SF) concentrations <25 μg/L. Women were randomly assigned to 3 groups to receive 20 g margarine, with 14 mg added iron as either micronized ground ferric pyrophosphate (MGFePP) or sodium iron edetate (NaFeEDTA), or placebo daily. We measured hemoglobin and iron status of subjects at 2 fixed time points (at baseline and the endpoint) plus 3 randomly assigned time points between 4 and 28 wk. With the use of bootstrapping, the number of observations per individual was reduced to 3 and then compared with the 5-time-point data. Mixed-effects models were used to estimate iron repletion over time for random sampling, and analysis of covariance was used for fixed time-point sampling.
RESULTS: Body iron stores increased in women who received MGFePP or NaFeEDTA compared with women who received placebo (P < 0.05). The increase in body iron stores with NaFeEDTA fortification was 2-3 times the increase with MGFePP fortification (P < 0.05); the difference was more marked in women with baseline SF concentrations <15 μg/L (P < 0.05). Random serial sampling reduced the required sample size per group to one-tenth of that for 2 fixed time points. Compared with the 5-time-point analysis, the 3-time-point sparse sampling generated comparable estimates of efficacy.
CONCLUSIONS: When used to evaluate the efficacy of iron fortificants, random serial sampling can reduce the sample size, invasiveness, and costs while increasing sensitivity. Random serial sampling more clearly describes the pattern of iron repletion and may prove useful in evaluating other micronutrient interventions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844068     DOI: 10.3945/ajcn.2010.29523

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  5 in total

1.  Increased Iron Status during a Feeding Trial of Iron-Biofortified Beans Increases Physical Work Efficiency in Rwandan Women.

Authors:  Sarah V Luna; Laura M Pompano; Mercy Lung'aho; Jean Bosco Gahutu; Jere D Haas
Journal:  J Nutr       Date:  2020-05-01       Impact factor: 4.798

2.  The effect of central obesity on inflammation, hepcidin, and iron metabolism in young women.

Authors:  Nicole U Stoffel; Carla El-Mallah; Isabelle Herter-Aeberli; Nour Bissani; Nour Wehbe; Omar Obeid; Michael B Zimmermann
Journal:  Int J Obes (Lond)       Date:  2020-01-23       Impact factor: 5.095

Review 3.  Micronutrient fortification of food and its impact on woman and child health: a systematic review.

Authors:  Jai K Das; Rehana A Salam; Rohail Kumar; Zulfiqar A Bhutta
Journal:  Syst Rev       Date:  2013-08-23

4.  Effect of iron and zinc-biofortified pearl millet consumption on growth and immune competence in children aged 12-18 months in India: study protocol for a randomised controlled trial.

Authors:  Saurabh Mehta; Julia L Finkelstein; Sudha Venkatramanan; Samantha L Huey; Shobha A Udipi; Padmini Ghugre; Caleb Ruth; Richard L Canfield; Anura V Kurpad; Ramesh D Potdar; Jere D Haas
Journal:  BMJ Open       Date:  2017-11-14       Impact factor: 2.692

5.  Effect of vitamin D3-fortified fruit juice supplementation of 4000 IU daily on the recovery of iron status in childbearing-aged women with marginally low iron stores: Protocol for an 8-week, parallel group, double-blind randomized controlled trial.

Authors:  Salma Faeza Ahmad Fuzi; Loh Su Peng; Nurzalinda Zabaha Zalbahar; Norhafizah Ab Manan; Muhammad Najib Mohamad Alwi
Journal:  PLoS One       Date:  2022-03-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.